Selecting Screening Candidates for Kinase and G Protein-Coupled Receptor Targets Using Neural Networks

A series of neural networks has been trained, using consensus methods, to recognize compounds that act at biological targets belonging to specific gene families. The MDDR database was used to provide compounds targeted against gene families and sets of randomly selected molecules. BCUT parameters were employed as input descriptors that encode structural properties and information relevant to ligand-receptor interactions. In each case, the networks identified over 80% of the compounds targeting a gene family. The technique was applied to purchasing compounds from external suppliers, and results from screening against one gene family demonstrated impressive abilities to predict the activity of the majority of known hit compounds.

[1]  F. Burden Molecular Identification Number for Substructure Searches. , 1989 .

[2]  Stephen D. Pickett,et al.  Diversity Profiling and Design Using 3D Pharmacophores: Pharmacophore-Derived Queries (PDQ) , 1996, J. Chem. Inf. Comput. Sci..

[3]  J. Mason,et al.  New perspectives in lead generation II: Evaluating molecular diversity , 1996 .

[4]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[5]  G. Rishton Reactive compounds and in vitro false positives in HTS , 1997 .

[6]  C. Hulme,et al.  Inhibitors of Tyrosine Kinases Involved in Inflammation and Autoimmune Disease , 1997 .

[7]  Ajay,et al.  Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.

[8]  John M. Barnard,et al.  Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..

[9]  Jonathan S. Mason,et al.  Chemistry Space Metrics in Diversity Analysis, Library Design, and Compound Selection , 1998, J. Chem. Inf. Comput. Sci..

[10]  H. Kubinyi,et al.  A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.

[11]  P. Willett,et al.  Identification of Biological Activity Profiles Using Substructural Analysis and Genetic Algorithms. , 1998 .

[12]  K. M. Smith,et al.  Novel software tools for chemical diversity , 1998 .

[13]  Mark A. Murcko,et al.  Virtual screening : an overview , 1998 .

[14]  F. Burden,et al.  New QSAR Methods Applied to Structure—Activity Mapping and Combinatorial Chemistry. , 1999 .

[15]  Robert S. Pearlman,et al.  Metric Validation and the Receptor-Relevant Subspace Concept , 1999, J. Chem. Inf. Comput. Sci..

[16]  J. Mason,et al.  New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. , 1999, Journal of medicinal chemistry.

[17]  Ajay,et al.  Designing libraries with CNS activity. , 1999, Journal of medicinal chemistry.

[18]  G. Bemis,et al.  Properties of known drugs. 2. Side chains. , 1999, Journal of medicinal chemistry.

[19]  D. Boschelli Small molecule inhibitors of receptor tyrosine kinases , 1999 .

[20]  Schmid,et al.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.

[21]  J. Bajorath,et al.  Database Searching for Compounds with Similar Biological Activity Using Short Binary Bit String Representations of Molecules. , 1999 .

[22]  D. Schnur Design and Diversity Analysis of Large Combinatorial Libraries Using Cell‐Based Methods. , 1999 .

[23]  J. Wang,et al.  Toward designing drug-like libraries: a novel computational approach for prediction of drug feasibility of compounds. , 1999, Journal of combinatorial chemistry.

[24]  Brian Hudson,et al.  Strategic Pooling of Compounds for High-Throughput Screening , 1999, J. Chem. Inf. Comput. Sci..

[25]  Stephen D. Pickett,et al.  Classification of Kinase Inhibitors Using BCUT Descriptors , 2000, J. Chem. Inf. Comput. Sci..

[26]  G M Keserû,et al.  A neural network based virtual high throughput screening test for the prediction of CNS activity. , 2000, Combinatorial chemistry & high throughput screening.

[27]  S. Venkatesh,et al.  Role of the development scientist in compound lead selection and optimization. , 2000, Journal of pharmaceutical sciences.

[28]  T N Thompson,et al.  Early ADME in support of drug discovery: the role of metabolic stability studies. , 2000, Current drug metabolism.

[29]  A Bucinski,et al.  Pharmacological classification of drugs based on neural network processing of molecular modeling data. , 2000, Combinatorial chemistry & high throughput screening.

[30]  J. Mason,et al.  Library design using BCUT chemistry-space descriptors and multiple four-point pharmacophore fingerprints: simultaneous optimization and structure-based diversity. , 2000, Journal of molecular graphics & modelling.

[31]  Johnson,et al.  Predicting human safety: screening and computational approaches. , 2000, Drug discovery today.

[32]  Martyn G. Ford,et al.  Unsupervised Forward Selection: A Method for Eliminating Redundant Variables , 2000, J. Chem. Inf. Comput. Sci..

[33]  J. Mason,et al.  Library design using BCUT chemistry-space descriptors and multiple four-point pharmacophore fingerprints: simultaneous optimization and structure-based diversity. , 2000, Journal of molecular graphics & modelling.

[34]  U. Lessel,et al.  In vitro and in silico affinity fingerprints: Finding similarities beyond structural classes , 2000 .

[35]  M. Wagener,et al.  Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features. , 2000 .

[36]  Jun Xu,et al.  Drug-like Index: A New Approach To Measure Drug-like Compounds and Their Diversity , 2000, J. Chem. Inf. Comput. Sci..

[37]  Jürgen Bajorath,et al.  Molecular Descriptors for Effective Classification of Biologically Active Compounds Based on Principal Component Analysis Identified by a Genetic Algorithm , 2000, J. Chem. Inf. Comput. Sci..

[38]  Robert Bywater,et al.  Improving the Odds in Discriminating "Drug-like" from "Non Drug-like" Compounds , 2000, J. Chem. Inf. Comput. Sci..

[39]  I. Muegge,et al.  Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.

[40]  Darren V. S. Green,et al.  Prediction of Biological Activity for High-Throughput Screening Using Binary Kernel Discrimination , 2001, J. Chem. Inf. Comput. Sci..

[41]  J. Drews Jürgen Drews discusses the future of the industry. Interviewed by Rebecca N. Lawrence. , 2001, Drug discovery today.

[42]  D. E. Clark,et al.  Prediction of intestinal absorption and blood-brain barrier penetration by computational methods. , 2001, Combinatorial chemistry & high throughput screening.

[43]  D. Kassel Combinatonial chemistry and mass spectrometry in the 21st century drug discovery laboratory. , 2001, Chemical reviews.

[44]  D. Kassel Combinatorial Chemistry and Mass Spectrometry in the 21st Century Drug Discovery Laboratory , 2001 .

[45]  R. García-Domenech,et al.  General topological patterns of known drugs. , 2001, Journal of molecular graphics & modelling.

[46]  Hua Gao,et al.  Application of BCUT Metrics and Genetic Algorithm in Binary QSAR Analysis , 2001, J. Chem. Inf. Comput. Sci..

[47]  J. Mason,et al.  The design of combinatorial libraries using properties and 3D pharmacophore fingerprints. , 2001, Drug discovery today.

[48]  J. Wölcke,et al.  Miniaturized HTS technologies - uHTS. , 2001, Drug discovery today.

[49]  S. Anzali,et al.  Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS). , 2001, Journal of medicinal chemistry.

[50]  Jun Xu,et al.  Drug-Like Index: A New Approach to Measure Drug-Like Compounds and Their Diversity. , 2001 .

[51]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[52]  J. Gittins,et al.  Prediction of Biological Activity for High-Throughput Screening Using Binary Kernel Discrimination. , 2001 .

[53]  A. Li,et al.  Screening for human ADME/Tox drug properties in drug discovery. , 2001, Drug discovery today.

[54]  Á. Furka Combinatorial chemistry: 20 years on... , 2002, Drug discovery today.

[55]  Gert Vriend,et al.  GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..